Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Designing nanotheranostics with machine learning

Rao, Lang, Yuan, Yuan, Shen, Xi, Yu, Guocan, Chen, Xiaoyuan · 2024 · Nature Nanotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41565-024-01753-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 120

  1. Chen, H., Zhang, W., Zhu, G., Xie, J. & Chen, X. Rethinking cancer nanotheranostics. Nat. Rev. Mater. 2, 17024 (2017). · DOI · Paper page
  2. Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17, 20–37 (2017). · DOI · Paper page
  3. AbdElFatah, T. et al. Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens. Nat. Nanotechnol. 18, 922–932 (2023). · DOI
  4. Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021). · DOI · Paper page
  5. Zhang, J., Zhao, T., Jakobsson, V. & Chen, X. Clinical translation of radiotheranostics for precision oncology. Nat. Rev. Bioeng. 1, 612–614 (2023). · DOI
  6. Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17, 657–674 (2020). · DOI · Paper page
  7. Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806–2827 (2022). · DOI · Paper page
  8. Nam, J. et al. Cancer nanomedicine for combination cancer immunotherapy. Nat. Rev. Mater. 4, 398–414 (2019). · DOI · Paper page
  9. Zhao, H. et al. A robotic platform for the synthesis of colloidal nanocrystals. Nat. Synth. 2, 505–514 (2023). · DOI · Paper page
  10. Huang, X. et al. Nanotechnology-based strategies against SARS-CoV-2 variants. Nat. Nanotechnol. 17, 1027–1037 (2022). · DOI
  11. Park, J. et al. An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma. Nat. Biomed. Eng. 5, 678–689 (2021). · DOI · Paper page
  12. Rao, L. et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat. Commun. 11, 4909 (2020). · DOI · Paper page
  13. Shen, D., Wu, G. & Suk, H.-I. Deep learning in medical image analysis. Annu. Rev. Biomed. Eng. 19, 221–248 (2017). · DOI · Paper page
  14. Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C. & Collins, J. J. Next-generation machine learning for biological networks. Cell 173, 1581–1592 (2018). · DOI · Paper page
  15. Ziatdinov, M., Ghosh, A., Wong, C. Y. & Kalinin, S. V. AtomAI framework for deep learning analysis of image and spectroscopy data in electron and scanning probe microscopy. Nat. Mach. Intell. 4, 1101–1112 (2022). · DOI
  16. Heinzmann, K., Carter, L. M., Lewis, J. S. & Aboagye, E. O. Multiplexed imaging for diagnosis and therapy. Nat. Biomed. Eng. 1, 697–713 (2017). · DOI · Paper page
  17. Wong, F., de la Fuente-Nunez, C. & Collins, J. J. Leveraging artificial intelligence in the fight against infectious diseases. Science 381, 164–170 (2023). · DOI · Paper page
  18. Chih-Wei, H. & Chih-Jen, L. A comparison of methods for multiclass support vector machines. IEEE Trans. Neural Netw. 13, 415–425 (2002). · DOI · Paper page
  19. Masson, J.-F., Biggins, J. S. & Ringe, E. Machine learning for nanoplasmonics. Nat. Nanotechnol. 18, 111–123 (2023). · DOI
  20. Wan, F., Wong, F., Collins, J. J. & de la Fuente-Nunez, C. Machine learning for antimicrobial peptide identification and design. Nat. Rev. Bioeng. 2, 392–407 (2024). · DOI · Paper page
  21. Mahmoudi, M., Landry, M. P., Moore, A. & Coreas, R. The protein corona from nanomedicine to environmental science. Nat. Rev. Mater. 8, 422–438 (2023). · DOI · Paper page
  22. Tao, H. et al. Nanoparticle synthesis assisted by machine learning. Nat. Rev. Mater. 6, 701–716 (2021). · DOI · Paper page
  23. Dai, X. & Chen, Y. Computational biomaterials: computational simulations for biomedicine. Adv. Mater. 35, 2204798 (2023). · DOI
  24. Batra, R. et al. Machine learning overcomes human bias in the discovery of self-assembling peptides. Nat. Chem. 14, 1427–1435 (2022). · DOI · Paper page
  25. Boehnke, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 377, eabm5551 (2022). · DOI · Paper page
  26. Yamankurt, G. et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat. Biomed. Eng. 3, 318–327 (2019). · DOI · Paper page
  27. Shamay, Y. et al. Quantitative self-assembly prediction yields targeted nanomedicines. Nat. Mater. 17, 361–368 (2018). · DOI · Paper page
  28. Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180–1194 (2021). · DOI · Paper page
  29. Lu, Y., Aimetti, A. A., Langer, R. & Gu, Z. Bioresponsive materials. Nat. Rev. Mater. 1, 16075 (2016). · DOI · Paper page
  30. Hong, G., Diao, S., Antaris, A. L. & Dai, H. Carbon nanomaterials for biological imaging and nanomedicinal therapy. Chem. Rev. 115, 10816–10906 (2015). · DOI · Paper page
  31. Suwardi, A. et al. Machine learning-driven biomaterials evolution. Adv. Mater. 34, 2102703 (2022). · DOI · Paper page
  32. Rycenga, M. et al. Controlling the synthesis and assembly of silver nanostructures for plasmonic applications. Chem. Rev. 111, 3669–3712 (2011). · DOI · Paper page
  33. Yang, X., Yang, M., Pang, B., Vara, M. & Xia, Y. Gold nanomaterials at work in biomedicine. Chem. Rev. 115, 10410–10488 (2015). · DOI · Paper page
  34. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005). · DOI · Paper page
  35. Kim, P. et al. Quantifying the efficacy of magnetic nanoparticles for MRI and hyperthermia applications via machine learning methods. Small 19, 2303522 (2023). · DOI
  36. Serov, N. & Vinogradov, V. Artificial intelligence to bring nanomedicine to life. Adv. Drug Deliv. Rev. 184, 114194 (2022). · DOI · Paper page
  37. Grand, J., Auguié, B. & Le Ru, E. C. Combined extinction and absorption UV–visible spectroscopy as a method for revealing shape imperfections of metallic nanoparticles. Anal. Chem. 91, 14639–14648 (2019). · DOI
  38. Gherman, A. M. M. et al. Artificial neural networks modeling of the parameterized gold nanoparticles generation through photo-induced process. Mater. Res. Express 5, 085011 (2018). · DOI
  39. Shafaei, A. & Khayati, G. R. A predictive model on size of silver nanoparticles prepared by green synthesis method using hybrid artificial neural network–particle swarm optimization algorithm. Measurement 151, 107199 (2020). · DOI
  40. Orimoto, Y. et al. Application of artificial neural networks to rapid data analysis in combinatorial nanoparticle syntheses. J. Phys. Chem. C 116, 17885–17896 (2012). · doi:10.1021/jp3031122
  41. Salley, D. et al. A nanomaterials discovery robot for the Darwinian evolution of shape programmable gold nanoparticles. Nat. Commun. 11, 2771 (2020). · DOI
  42. Ng, K. K. & Zheng, G. Molecular interactions in organic nanoparticles for phototheranostic applications. Chem. Rev. 115, 11012–11042 (2015). · DOI · Paper page
  43. Andrews, N. et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N. Engl. J. Med. 386, 1532–1546 (2022). · doi:10.1056/nejmoa2119451 · Paper page
  44. Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410–1415 (2023). · DOI · Paper page
  45. Wang, W. et al. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm. Acta Pharm. Sin. B 12, 2950–2962 (2022). · DOI · Paper page
  46. Youshia, J., Ali, M. E. & Lamprecht, A. Artificial neural network based particle size prediction of polymeric nanoparticles. Eur. J. Pharm. Biopharm. 119, 333–342 (2017). · DOI
  47. Shalaby, K. S. et al. Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks. Int. J. Nanomed. 9, 4953–4964 (2014).
  48. Meng, Q.-F. et al. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Sci. Adv. 9, eadg3277 (2023). · DOI
  49. Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016). · DOI · Paper page
  50. Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748–759 (2021). · DOI · Paper page
  51. Madigan, V., Zhang, F. & Dahlman, J. E. Drug delivery systems for CRISPR-based genome editors. Nat. Rev. Drug Discov. 22, 875–894 (2023). · DOI · Paper page
  52. Zengel, J. et al. Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression. Nat. Methods 20, 1070–1081 (2023). · DOI
  53. Bryant, D. H. et al. Deep diversification of an AAV capsid protein by machine learning. Nat. Biotechnol. 39, 691–696 (2021). · DOI · Paper page
  54. El Andaloussi, S., Mäger, I., Breakefield, X. O. & Wood, M. J. A. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347–357 (2013). · DOI · Paper page
  55. Zheng, W. et al. Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples. Nat. Biomed. Eng. 6, 979–991 (2022). · DOI
  56. Kuypers, S. et al. Unsupervised machine learning-based clustering of nanosized fluorescent extracellular vesicles. Small 17, 2006786 (2021). · DOI
  57. Mahmoudi, M. et al. Protein−nanoparticle interactions: opportunities and challenges. Chem. Rev. 111, 5610–5637 (2011). · DOI · Paper page
  58. Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8, 137–143 (2013). · DOI · Paper page
  59. Nel, A. E. et al. Understanding biophysicochemical interactions at the nano–bio interface. Nat. Mater. 8, 543–557 (2009). · DOI · Paper page
  60. Kingston, B. R., Syed, A. M., Ngai, J., Sindhwani, S. & Chan, W. C. W. Assessing micrometastases as a target for nanoparticles using 3D microscopy and machine learning. Proc. Natl Acad. Sci. USA 116, 14937–14946 (2019). · DOI
  61. Ferdosi, S. et al. Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano–bio interactions. Proc. Natl Acad. Sci. USA 119, e2106053119 (2022). · DOI
  62. Cha, M. et al. Unifying structural descriptors for biological and bioinspired nanoscale complexes. Nat. Comput. Sci. 2, 243–252 (2022). · doi:10.1038/s43588-022-00229-w
  63. Ban, Z. et al. Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles. Proc. Natl Acad. Sci. USA 117, 10492–10499 (2020). · DOI · Paper page
  64. Ouassil, N., Pinals, R. L., Del Bonis-O’Donnell, J. T., Wang, J. W. & Landry, M. P. Supervised learning model predicts protein adsorption to carbon nanotubes. Sci. Adv. 8, eabm0898 (2022). · DOI
  65. Saldinger, J. C., Raymond, M., Elvati, P. & Violi, A. Domain-agnostic predictions of nanoscale interactions in proteins and nanoparticles. Nat. Comput. Sci. 3, 393–402 (2023). · DOI
  66. Liu, R., Jiang, W., Walkey, C. D., Chan, W. C. W. & Cohen, Y. Prediction of nanoparticles–cell association based on corona proteins and physicochemical properties. Nanoscale 7, 9664–9675 (2015). · DOI
  67. Lazarovits, J. et al. Supervised learning and mass spectrometry predicts the in vivo fate of nanomaterials. ACS Nano 13, 8023–8034 (2019). · DOI · Paper page
  68. Fourches, D. et al. Quantitative nanostructure−activity relationship modeling. ACS Nano 4, 5703–5712 (2010). · DOI · Paper page
  69. Walkey, C. D. et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8, 2439–2455 (2014). · DOI · Paper page
  70. Loecher, A., Bruyns-Haylett, M., Ballester, P. J., Borros, S. & Oliva, N. A machine learning approach to predict cellular uptake of pBAE polyplexes. Biomater. Sci. 11, 5797–5808 (2023). · DOI
  71. Shirokii, N. et al. Quantitative prediction of inorganic nanomaterial cellular toxicity via machine learning. Small 19, 2207106 (2023). · DOI
  72. Martin et al. Evidence-based prediction of cellular toxicity for amorphous silica nanoparticles. ACS Nano 17, 9987–9999 (2023). · DOI
  73. Jyakhwo, S., Serov, N., Dmitrenko, A. & Vinogradov, V. V. Machine learning reinforced genetic algorithm for massive targeted discovery of selectively cytotoxic inorganic nanoparticles. Small 20, 2305375 (2024). · DOI
  74. Puzyn, T. et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 6, 175–178 (2011). · DOI · Paper page
  75. Sealfon, R. S. G., Wong, A. K. & Troyanskaya, O. G. Machine learning methods to model multicellular complexity and tissue specificity. Nat. Rev. Mater. 6, 717–729 (2021). · DOI
  76. Chen, Q. et al. Meta-analysis of nanoparticle distribution in tumors and major organs in tumor-bearing mice. ACS Nano 17, 19810–19831 (2023). · DOI
  77. MacMillan, P. et al. Toward predicting nanoparticle distribution in heterogeneous tumor tissues. Nano Lett. 23, 7197–7205 (2023). · DOI
  78. Liu, X. et al. Predictive modeling of nanomaterial exposure effects in biological systems. Int. J. Nanomed. 8, 31–43 (2023).
  79. Gilbertson, L. M. et al. Toward safer multi-walled carbon nanotube design: establishing a statistical model that relates surface charge and embryonic zebrafish mortality. Nanotoxicology 10, 10–19 (2016).
  80. Song, Y. et al. 3D-printed epifluidic electronic skin for machine learning-powered multimodal health surveillance. Sci. Adv. 9, eadi6492 (2023). · DOI · Paper page
  81. Lin, A. A., Nimgaonkar, V., Issadore, D. & Carpenter, E. L. Extracellular vesicle-based multianalyte liquid biopsy as a diagnostic for cancer. Annu. Rev. Biomed. Data Sci. 5, 269–292 (2022). · DOI
  82. Altug, H., Oh, S.-H., Maier, S. A. & Homola, J. Advances and applications of nanophotonic biosensors. Nat. Nanotechnol. 17, 5–16 (2022). · DOI · Paper page
  83. Safir, F. et al. Combining acoustic bioprinting with AI-assisted raman spectroscopy for high-throughput identification of bacteria in blood. Nano Lett. 23, 2065–2073 (2023). · DOI
  84. Shin, H. et al. Single test-based diagnosis of multiple cancer types using exosome-SERS-AI for early stage cancers. Nat. Commun. 14, 1644 (2023). · DOI · Paper page
  85. Kavungal, D. et al. Artificial intelligence-coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases. Sci. Adv. 9, eadg9644 (2023). · DOI
  86. Gao, Z. et al. Machine-learning-assisted microfluidic nanoplasmonic digital immunoassay for cytokine storm profiling in COVID-19 patients. ACS Nano 15, 18023–18036 (2021). · DOI
  87. Thrift, W. J. et al. Deep learning analysis of vibrational spectra of bacterial lysate for rapid antimicrobial susceptibility testing. ACS Nano 14, 15336–15348 (2020). · DOI
  88. Wang, Y., Zhao, Y., Bollas, A., Wang, Y. & Au, K. F. Nanopore sequencing technology, bioinformatics and applications. Nat. Biotechnol. 39, 1348–1365 (2021). · DOI · Paper page
  89. Zhang, M. et al. Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore. Nat. Methods 21, 609–618 (2024). · DOI
  90. Ying, Y.-L. et al. Nanopore-based technologies beyond DNA sequencing. Nat. Nanotechnol. 17, 1136–1146 (2022). · DOI · Paper page
  91. Jena, M. K. & Pathak, B. Development of an artificially intelligent nanopore for high-throughput DNA sequencing with a machine-learning-aided quantum-tunneling approach. Nano Lett. 23, 2511–2521 (2023). · DOI
  92. Taniguchi, M. et al. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection. Nat. Commun. 12, 3726 (2021). · DOI
  93. Xia, K. et al. Synthetic heparan sulfate standards and machine learning facilitate the development of solid-state nanopore analysis. Proc. Natl Acad. Sci. USA 118, e2022806118 (2021). · DOI
  94. Li, M. et al. Identification of tagged glycans with a protein nanopore. Nat. Commun. 14, 1737 (2023). · DOI
  95. Greive, S. J., Bacri, L., Cressiot, B. & Pelta, J. Identification of conformational variants for bradykinin biomarker peptides from a biofluid using a nanopore and machine learning. ACS Nano 18, 539–550 (2024). · DOI
  96. Sajda, P. Machine learning for detection and diagnosis of disease. Annu. Rev. Biomed. Eng. 8, 537–565 (2006). · DOI · Paper page
  97. Tian, F. et al. Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer. Nat. Commun. 12, 2536 (2021). · DOI · Paper page
  98. Sahu, A. et al. Regulation of aged skeletal muscle regeneration by circulating extracellular vesicles. Nat. Aging 1, 1148–1161 (2021). · DOI
  99. Mangalwedhekar, R. et al. Achieving nanoscale precision using neuromorphic localization microscopy. Nat. Nanotechnol. 18, 380–389 (2023). · DOI
  100. Reis, M. et al. Machine-learning-guided discovery of 19F MRI agents enabled by automated copolymer synthesis. J. Am. Chem. Soc. 143, 17677–17689 (2021). · DOI
  101. Moen, E. et al. Deep learning for cellular image analysis. Nat. Methods 16, 1233–1246 (2019). · DOI · Paper page
  102. Bouchard, C. et al. Resolution enhancement with a task-assisted GAN to guide optical nanoscopy image analysis and acquisition. Nat. Mach. Intell. 5, 830–844 (2023). · DOI
  103. Park, J. et al. Artificial intelligence-enabled quantitative phase imaging methods for life sciences. Nat. Methods 20, 1645–1660 (2023). · DOI
  104. Hong, G. et al. Through-skull fluorescence imaging of the brain in a new near-infrared window. Nat. Photon. 8, 723–730 (2014). · DOI · Paper page
  105. Chen, X. et al. Artificial confocal microscopy for deep label-free imaging. Nat. Photon. 17, 250–258 (2023). · DOI
  106. Ham, D., Park, H., Hwang, S. & Kim, K. Neuromorphic electronics based on copying and pasting the brain. Nat. Electron. 4, 635–644 (2021). · DOI · Paper page
  107. Oumano, M. & Yu, H. A deep learning approach to gold nanoparticle quantification in computed tomography. Phys. Med. 87, 83–89 (2021). · DOI
  108. Reker, D. et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nat. Nanotechnol. 16, 725–733 (2021). · DOI · Paper page
  109. Hsueh, H. T. et al. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery. Nat. Commun. 14, 2509 (2023). · DOI
  110. Castillo-Hair, S. M. & Seelig, G. Machine learning for designing next-generation mRNA therapeutics. Acc. Chem. Res. 55, 24–34 (2022). · DOI
  111. Ebrahimi, S. B., Samanta, D., Kusmierz, C. D. & Mirkin, C. A. Protein transfection via spherical nucleic acids. Nat. Protoc. 17, 327–357 (2022). · DOI
  112. Huang, J. et al. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat. Biomed. Eng. 7, 797–810 (2023). · DOI · Paper page
  113. O’Callaghan, J. How OpenAI’s text-to-video tool Sora could change science—and society. Nature 627, 475–476 (2024). · doi:10.1038/d41586-024-00661-0
  114. de la Iglesia, D. et al. A machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.gov. PLoS ONE 9, e110331 (2014). · DOI
  115. Wyrzykowska, E. et al. Representing and describing nanomaterials in predictive nanoinformatics. Nat. Nanotechnol. 17, 924–932 (2022). · DOI
  116. Erion, G. et al. A cost-aware framework for the development of AI models for healthcare applications. Nat. Biomed. Eng. 6, 1384–1398 (2022). · DOI
  117. Yan, X., Sedykh, A., Wang, W., Yan, B. & Zhu, H. Construction of a web-based nanomaterial database by big data curation and modeling friendly nanostructure annotations. Nat. Commun. 11, 2519 (2020). · DOI
  118. Wang, Y. & Kohane, D. S. External triggering and triggered targeting strategies for drug delivery. Nat. Rev. Mater. 2, 17020 (2017). · DOI · Paper page
  119. Ling, Q., Herstine, J. A., Bradbury, A. & Gray, S. J. AAV-based in vivo gene therapy for neurological disorders. Nat. Rev. Drug Discov. 22, 789–806 (2023). · DOI · Paper page
  120. Hu, S. et al. A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery. Nat. Commun. 12, 1689 (2021). · DOI · Paper page

Metadata

Authors
Rao, L., Yuan, Y., Shen, X., Yu, G., & Chen, X.
Venue
Nature Nanotechnology
Published
2024-10-03
Volume
19
Issue
12
Pages
1769-1781
ISSN
  • 1748-3387 (ISSN-L)
  • 1748-3395
OpenAlex
W4403104495
Cited by
207
References
28
FWCI
17.30
Type
journal article
Language
en
Open access
closed
Licence
Funders
National University of Singapore (NUHSRO/2020/133/Startup/08)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Designing nanotheranostics with machine learning. https://app.cochat.ai/papers/10.1038/s41565-024-01753-8
The paper
Rao, L., Yuan, Y., Shen, X., Yu, G., & Chen, X. (2024). Designing nanotheranostics with machine learning. Nature Nanotechnology. https://doi.org/10.1038/s41565-024-01753-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.